- Home
- IRON vs INSW Comparison
IRON vs INSW Comparison
Compare IRON & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- INSW
- Stock Information
- Founded
- IRON 2017
- INSW 1999
- Country
- IRON United States
- INSW United States
- Employees
- IRON N/A
- INSW N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- INSW Semiconductors
- Sector
- IRON Health Care
- INSW Technology
- Exchange
- IRON Nasdaq
- INSW Nasdaq
- Market Cap
- IRON 1.9B
- INSW 2.0B
- IPO Year
- IRON N/A
- INSW N/A
- Fundamental
- Price
- IRON $58.25
- INSW $38.45
- Analyst Decision
- IRON Strong Buy
- INSW Strong Buy
- Analyst Count
- IRON 10
- INSW 3
- Target Price
- IRON $73.70
- INSW $60.67
- AVG Volume (30 Days)
- IRON 267.1K
- INSW 1.4M
- Earning Date
- IRON 11-12-2024
- INSW 02-27-2025
- Dividend Yield
- IRON N/A
- INSW 15.01%
- EPS Growth
- IRON N/A
- INSW N/A
- EPS
- IRON N/A
- INSW 10.33
- Revenue
- IRON N/A
- INSW $1,007,734,000.00
- Revenue This Year
- IRON N/A
- INSW N/A
- Revenue Next Year
- IRON N/A
- INSW $1.61
- P/E Ratio
- IRON N/A
- INSW $3.72
- Revenue Growth
- IRON N/A
- INSW N/A
- 52 Week Low
- IRON $25.60
- INSW $32.11
- 52 Week High
- IRON $77.60
- INSW $65.94
- Technical
- Relative Strength Index (RSI)
- IRON 40.61
- INSW 51.17
- Support Level
- IRON $57.09
- INSW $40.30
- Resistance Level
- IRON $61.08
- INSW $41.62
- Average True Range (ATR)
- IRON 2.83
- INSW 1.37
- MACD
- IRON -0.58
- INSW 0.57
- Stochastic Oscillator
- IRON 14.04
- INSW 48.44
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.